Issue: Volume VII No. 14 - October 2, 2000

Management Execution Makes a Difference

THERE’S PLENTY OF HOOROAR AND EXCITEMENT about skyrocketing stock prices for several public lab and pathology companies in 2000! But this crusty old curmudgeon has been around the investment industry too long to accept Wall Street’s new-found enthusiasm for clinical laboratories as definitive proof of the lab industry’s financial turnaround. For example, it’s exciting to see …

Management Execution Makes a Difference Read More »

Specialty Labs Prepares For Public Stock Offering

CEO SUMMARY: Stock prices for public lab companies zoomed upwards through 2000. For this reason, executives at Specialty Laboratories, Inc. believe it is an auspicious time for their laboratory to bring an initial public offering (IPO) to market. Company officials recently filed a stock registration document with the SEC which provides new insights about the …

Specialty Labs Prepares For Public Stock Offering Read More »

Successful Specialty IPO Can Open Door for Others

CEO SUMMARY: It’s no secret that a handful of laboratory companies would like to complete an initial public offering (IPO). If Specialty Labs’ public offering goes well, expect these lab companies to bring their own stock offerings to the public equity markets. As the number of public lab companies increases, the competitive marketplace for laboratory …

Successful Specialty IPO Can Open Door for Others Read More »

National Esoteric/Reference Rankings

Little is known about how the marketplace for hospital send-out testing is divided among national laboratory competitors.These rankings mark the second year THE DARK REPORT has attempted to measure the market for hospital esoteric and reference testing. This ranking does not include niche or specialty laboratory companies which provide specific lines of testing to hospital …

National Esoteric/Reference Rankings Read More »

Bill Bonello Sees Opportunities In Diagnostic Services Companies

CEO SUMMARY: With the clinical laboratory industry now enjoying growing interest by professional investors, THE DARK REPORT traveled to New York City to meet with financial analyst William B. Bonello, of U S Bancorp Piper Jaffray. Bonello co-authored a just-released overview of what he calls the “diagnostic services industry.” He is bullish on the future …

Bill Bonello Sees Opportunities In Diagnostic Services Companies Read More »

Piper Jaffray Illustrates “New” Paradigm for Role of Lab Tests

WHEN FINANCIAL ANALYST William B. Bonello issued his overview report on the diagnostic services industry last week, little did he know that one element of his report would prove an instant hit with lab industry executives. During the U.S. Bancorp Piper Jaffray conference last Thursday, at least four companies included Bonello’s “paradigm shift” diagram (see …

Piper Jaffray Illustrates “New” Paradigm for Role of Lab Tests Read More »

Is it Early-90s “Deja Vu” For Today’s Lab Industry?

CEO SUMMARY: Stock prices for laboratory and pathology companies have skyrocketed since the new decade of the 2000s dawned on January 1. Is investor optimism warranted by the opportunities ahead in diagnostic testing? Or will history repeat itself if the continuing evolution of American healthcare proves as financially unhealthy to independent lab and pathology firms …

Is it Early-90s “Deja Vu” For Today’s Lab Industry? Read More »

“October 2, 2000 Intelligence: Late Breaking Lab News”

More clinical laboratories are interested in obtaining ISO-9000 certification. The laboratory divisions of Kaiser Permanente-Southern California and Kaiser Permanente-Northern California are each preparing for an ISO-9000 certification effort. As reported in this issue of THE DARK REPORT, Specialty Laboratories, Inc. expects to pursue ISO-9001 certification during 2001. ADD TO: LAB ISO-9000 Meanwhile, Quest Diagnostics Incorporated …

“October 2, 2000 Intelligence: Late Breaking Lab News” Read More »